VDY

3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL

Created: 2001-05-18
Last modified:  2021-03-01

Find related ligands:

Chemical Details

Formal Charge0
Atom Count73
Chiral Atom Count5
Bond Count75
Aromatic Bond Count0
2D diagram of VDY

Chemical Component Summary

Name3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL
Synonyms25-HYDROXYVITAMIN D3
Systematic Name (OpenEye OEToolkits)(1S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methyl-heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
FormulaC27 H44 O2
Molecular Weight400.637
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04OC3CC(=C/C=C1\CCCC2(C)C(C(C)CCCC(O)(C)C)CCC12)/C(=C)CC3
SMILESCACTVS3.341C[CH](CCCC(C)(C)O)[CH]1CC[CH]2C(CCC[C]12C)=CC=C3C[CH](O)CCC3=C
SMILESOpenEye OEToolkits1.5.0CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
Canonical SMILESCACTVS3.341 C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)CCC3=C
Canonical SMILESOpenEye OEToolkits1.5.0 C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](CCC3=C)O)C
InChIInChI1.03 InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1
InChIKeyInChI1.03 JWUBBDSIWDLEOM-DTOXIADCSA-N

Drug Info: DrugBank

DrugBank IDDB00146 
NameCalcifediol
Groups
  • nutraceutical
  • approved
DescriptionThe major circulating metabolite of vitamin D3 (cholecalciferol). It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
Synonyms
  • (3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
  • 25-hydroxycholecalciferol
  • (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
  • Calcidiol
  • Calcifediol
Brand NamesRayaldee
IndicationUsed to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.
Categories
  • Alimentary Tract and Metabolism
  • Anti-Parathyroid Agents
  • Bone Density Conservation Agents
  • Calcium Homeostasis
  • Cholestanes
ATC-Code
  • A11CC06
  • H05BX05
CAS number19356-17-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Vitamin D3 receptorMEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRR...unknownagonist
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialMTQTLKYASRVFHRVRWAPELGASLGYREYHSARRSLADIPGPSTPSFLA...unknownsubstrate
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialMSSPISKSRSLAAFLQQLRSPRQPPRLVTSTAYTSPQPREVPVCPLTAGG...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1040
PubChem 5283731
ChEMBL CHEMBL1040
ChEBI CHEBI:17933, CHEBI:94743